ArticleTranslational oncology2018

CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma.

Yu-Feng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.